Big Pharma Recalls Millions of Pills Over Risk of Poisoning Children

Pfizer Recalls Millions of Pills Over Risk of Poisoning Children

Pharmacies nationwide sold the medication packages from December 2021 through March 2023

BECKER NEWS

Pfizer has recalled over four million packages of Nurtec ODT due to the risk of poisoning children.  The recall was announced by the United States Consumer Product Safety Commission (CPSC).

Pfizer is recalling the medication, typically used to treat migraines, because it is currently in a blister packet that is not deemed “child resistant” and therefore poses a possible risk to children. “Child resistant” packaging, obviously, must be significantly challenging for a child under five to open it, the CPSC says.

Nurtec ODT users can contact Pfizer to receive a free child-resistant pouch to put the medication in, according to the safety commission.

Nurtec ODT #Recall to provide child resistant pouches to patients for storage of their medicine. Click link for details. https://t.co/B9zEvxLulC pic.twitter.com/MmCnL6DDA0

— Nurtec® ODT (rimegepant) (@NurtecODT) March 16, 2023

“The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children,” the CPSC said.

Pfizer is recalling 4.2 million packages of Nurtec ODT, which contain eight 75 mg disintegrating tablets each. The Poison Prevention Safety Act (PPPA) requires this medication to be in child-resistant packaging.

“The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, NDC number and expiration date,” the safety commission said.

Pharmacies nationwide sold the medication packages from December 2021 through March 2023.

Nurtec’s statement explains there is no need to return Nurtec packages and adds that the “recall” refers to any situation where a product needs repair, replacement, refund, or notice/warning.

In 2022, Pfizer reported revenues of $100.3 Billion, an all-time high for the pharmaceutical company. It attributed its revenue growth to Paxlovid and Comirnaty, the commercial name for its mRNA Covid vaccine.

*********

(TLB) published this article from Becker News as compiled and written by Kyle Becker

Header featured image (edited) credit:  Bottle pills/org. BN article

Emphasis added by (TLB) editors

••••

••••

Stay tuned to …

••••

The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)

••••

Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.

••••

Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.

••••

Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.